Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LJF for Non-alcoholic Fatty Liver
NCT07637006Phase 2Not yet recruiting
- Sponsor
- Hong Kong Baptist University
- Start
- Sep 2026
- Primary completion
- Jul 2028
01
Overview
A Phase 2 trial of Linzhi Jianghuang Fufang Huoxue Anshen Capsule in non-alcoholic fatty liver disease (NAFLD), sponsored by Hong Kong Baptist University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Linzhi Jianghuang Fufang Huoxue Anshen Capsule
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT07637006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07637006.